Chikungunya vaccine approved for select groups by CDC advisory panel
STAT
FEBRUARY 28, 2024
In a global first, some travelers and laboratory researchers who are at risk of contracting chikungunya will soon be allowed to be vaccinated against the virus. A committee of vaccine experts recommended Wednesday that those selective groups of people should be offered access to the new vaccine, Ixchiq, which is made by Valneva Austria GmbH.
Let's personalize your content